Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life
- 1 June 2000
- journal article
- research article
- Published by Elsevier in Schizophrenia Research
- Vol. 43 (2-3) , 135-145
- https://doi.org/10.1016/s0920-9964(99)00154-1
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Which atypical antipsychotic?The British Journal of Psychiatry, 1998
- 756: The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone and conventional antipsychoticsSchizophrenia Research, 1997
- Adverse Effects of Antipsychotic AgentsDrugs, 1996
- Medical Complications of New Antipsychotic DrugsSchizophrenia Bulletin, 1996
- A Self-Rating Scale for Measuring Neuroleptic Side-EffectsThe British Journal of Psychiatry, 1995
- Will the new antipsychotics improve the treatment of schizophrenia?BMJ, 1993
- Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measuresPsychological Medicine, 1992
- A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validityPsychological Medicine, 1983
- The Sickness Impact Profile: Development and Final Revision of a Health Status MeasureMedical Care, 1981
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970